Impact of Colchicine and Low-dose Naltrexone on COVID-19

NCT04756128 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

142

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Colchicine 0.6 mg
DRUG: Naltrexone

Sponsor

HealthPartners Institute

Collaborators

[object Object]